UNLABELLED: In asthma, the relationship among airway inflammation, airway hyperresponsiveness, and lung function is poorly understood. Methods to noninvasively assess these relationships in human subjects are needed. We sought to determine whether (18)F-FDG uptake rate (K(i), min(-1)) could serve as a biomarker of eosinophilic inflammation and local lung function. METHODS: We used PET/CT to assess regional pulmonary perfusion (Q), specific ventilation per unit volume (sV(A)), fractional gas content (Fgas), airway wall thickness, and regional K(i) 10 h after segmental allergen challenge to the right middle lobe in 6 asthmatic subjects with demonstrated atopy. Q, sV(A), and Fgas in the allergen-challenged lobe were compared with the right upper lobe, where diluent was applied as a control. The airway wall thickness aspect ratio (ω) of the allergen-challenged airway was compared with those of similarly sized airways from unaffected areas of the lung. Differences in K(i) between allergen and diluent segments were compared with those in cell counts obtained 24 h after the allergen challenge by a bronchoalveolar lavage of the respective segments. RESULTS: We found systematic reductions in regional Q, sV(A), and Fgas and increased ω in all subjects. The ratio of eosinophil count (allergen to diluent) was linearly related (R(2) = 0.9917, P < 0.001) to the ratio of K(i). CONCLUSION: Regional K(i) measured with PET is a noninvasive and highly predictive biomarker of eosinophilic airway inflammation and its functional effects. This method may serve to help in the understanding of allergic inflammation and test the therapeutic effectiveness of novel drugs or treatments.
UNLABELLED: In asthma, the relationship among airway inflammation, airway hyperresponsiveness, and lung function is poorly understood. Methods to noninvasively assess these relationships in human subjects are needed. We sought to determine whether (18)F-FDG uptake rate (K(i), min(-1)) could serve as a biomarker of eosinophilic inflammation and local lung function. METHODS: We used PET/CT to assess regional pulmonary perfusion (Q), specific ventilation per unit volume (sV(A)), fractional gas content (Fgas), airway wall thickness, and regional K(i) 10 h after segmental allergen challenge to the right middle lobe in 6 asthmatic subjects with demonstrated atopy. Q, sV(A), and Fgas in the allergen-challenged lobe were compared with the right upper lobe, where diluent was applied as a control. The airway wall thickness aspect ratio (ω) of the allergen-challenged airway was compared with those of similarly sized airways from unaffected areas of the lung. Differences in K(i) between allergen and diluent segments were compared with those in cell counts obtained 24 h after the allergen challenge by a bronchoalveolar lavage of the respective segments. RESULTS: We found systematic reductions in regional Q, sV(A), and Fgas and increased ω in all subjects. The ratio of eosinophil count (allergen to diluent) was linearly related (R(2) = 0.9917, P < 0.001) to the ratio of K(i). CONCLUSION: Regional K(i) measured with PET is a noninvasive and highly predictive biomarker of eosinophilic airway inflammation and its functional effects. This method may serve to help in the understanding of allergic inflammation and test the therapeutic effectiveness of novel drugs or treatments.
Authors: C M Lilly; H Nakamura; O I Belostotsky; K J Haley; E A Garcia-Zepeda; A D Luster; E Israel Journal: Am J Respir Crit Care Med Date: 2001-06 Impact factor: 21.405
Authors: Hazel A Jones; Karen A Cadwallader; Jessica F White; Mohib Uddin; A Michael Peters; Edwin R Chilvers Journal: J Nucl Med Date: 2002-05 Impact factor: 10.057
Authors: Delphine L Chen; Timothy J Bedient; James Kozlowski; Daniel B Rosenbluth; Warren Isakow; Thomas W Ferkol; Betsy Thomas; Mark A Mintun; Daniel P Schuster; Michael J Walter Journal: Am J Respir Crit Care Med Date: 2009-07-02 Impact factor: 21.405
Authors: Guido Musch; Tilo Winkler; R Scott Harris; Marcos F Vidal Melo; Tyler J Wellman; Nicolas de Prost; Richard L Kradin; Jose G Venegas Journal: Anesthesiology Date: 2014-03 Impact factor: 7.892
Authors: Luciano Gattinoni; John J Marini; Antonio Pesenti; Michael Quintel; Jordi Mancebo; Laurent Brochard Journal: Intensive Care Med Date: 2016-01-18 Impact factor: 17.440
Authors: Rosana S Rodrigues; Fernando A Bozza; Christopher J Hanrahan; Li-Ming Wang; Qi Wu; John M Hoffman; Guy A Zimmerman; Kathryn A Morton Journal: Nucl Med Biol Date: 2017-01-17 Impact factor: 2.408
Authors: Vanessa J Kelly; Kathryn A Hibbert; Puja Kohli; Mamary Kone; Elliot E Greenblatt; Jose G Venegas; Tilo Winkler; R Scott Harris Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: Tyler J Wellman; Nicolas de Prost; Mauro Tucci; Tilo Winkler; Rebecca M Baron; Piotr Filipczak; Benjamin Raby; Jen-Hwa Chu; R Scott Harris; Guido Musch; Luiz F Dos Reis Falcao; Vera Capelozzi; Jose G Venegas; Marcos F Vidal Melo Journal: Anesthesiology Date: 2016-11 Impact factor: 7.892